Related Experiment Videos
[Circulating platelet aggregates in patients with acute ischemic and so-called chronic cerebrovascular disorders]
Insights
A modified platelet function test effectively identified changes in platelet aggregation in patients with cerebral infarction and transient ischemic attacks. This routine method shows promise for diagnosing cerebrovascular insufficiency.
Area of Science:
- Hematology
- Neurology
- Vascular Medicine
Context:
- Platelet function plays a critical role in cerebrovascular diseases.
- Assessing platelet aggregation is crucial for understanding thrombotic events.
- Routine diagnostic methods for platelet dysfunction in neurological patients are needed.
Purpose:
- To evaluate a modified platelet function test as a routine diagnostic tool.
- To identify specific alterations in platelet function in patients with cerebrovascular conditions.
- To determine the sensitivity of the test in detecting cerebrovascular insufficiency.
Summary:
- A modified platelet function test was applied to 71 healthy individuals and 96 patients with cerebrovascular conditions.
- Significant changes in platelet function were observed in patients with cerebral infarction and transient ischemic attacks.
- Increased platelet aggregation was noted in patients with cerebrovascular insufficiency, though values exceeded 3 standard deviations above the control mean in only 46% of cases.
Impact:
- This modified test offers a potential routine method for assessing platelet function in neurological patients.
- Findings highlight the utility of platelet function tests in diagnosing and understanding cerebrovascular insufficiency.
- Further validation may enhance the diagnostic accuracy of platelet aggregation assays in stroke patients.
Abstract:
A modified platelet function test was assessed as a routine method in 71 normal subjects and 96 patients. In patients with cerebral infarction (33) and those with transitory ischaemic attacks (30) definite changes in platelet function were demonstrated. In patients with cerebrovascular insufficiency (33) there was significantly increased platelet aggregation, but in only 46% of these patients were the values over 3 standard deviations above the mean of the control group (71).